secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2026-03-23T23:59:59+00:00
Accession:  0001493152-26-012062
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce corrects scrivener's error in Series B Preferred Stock designation
--------------------------------------------------------------------------

- Filed Certificate of Correction on March 18, 2026 to fix a scrivener's error in the Series B Preferred Stock designation.
- Correction is to the Certificate of Designation, which is part of the Certificate of Incorporation.
- No change in the rights or terms of the Series B Preferred Stock as a result of the correction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315226012062/0001493152-26-012062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315226012062/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-012062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer